Infection after the use of INFIX in Pelvic Ring Injuries

Open Access

Table 2

Infection isolation and treatment data.

	Bug isolated	Hospital Abx	Discharge Abx	Out pt tx
1	Strep. agalactiae	Vancomycin iv	Clindamycin po	6 weeks
2	MSSA	Sulfamethoxazole & trimethoprim double strength po	Sulfamethoxazole & trimethoprim double strength po	2 weeks
3	Enterobacter cloacae	Ertapenem iv	Ciprofloxacin po	2 weeks
4	MSSA	Ceftriaxone iv	Clindamycin po	4 weeks
5	Corynebacterium, Staphylococcus epidermidis, Proteus mirabilis	Clindamycin iv	Clindamycin po	2 weeks
6	MRSA	Vancomycin iv	Vancomycin iv	6 weeks
7	MSSA	Vancomycin iv	Sulfamethoxazole & trimethoprim double strength po	2 weeks
8	MRSA	Vancomycin iv	Sulfamethoxazole & trimethoprim double strength po	2 weeks
9	Enterobacter cloacae	Ertapenem iv	Ciprofloxacin po	2 weeks
10	MSSA	Cefazolin iv	Cefazolin iv	2 weeks

MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin sensitive Staphylococcus aureus; iv, intravenous; po, oral (par os).

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.